AstraZeneca: all 4,196 studies
Page 27 of 42. Open to participants first (299), then studies with results posted, then the rest; newest registration first within each.
- Autoinjector Device Assessment StudyCompletedNCT02349802Phase 1
- Observational Multicenter Non-interventional Study on COPD Patients Treatment Strategies at the Time of Hospital Discharge and Within 12 Months of Follow-up on an Outpatient Primary Care BasementCompletedNCT02346292
- A Study to Identify and Characterize LAL-D Patients in High-risk PopulationsTerminatedNCT02345421
- DISCOVERing Treatment Reality of Type 2 Diabetes in Real World SettingsCompletedNCT02322762
- An epidemiOlogy Study to deteRmine the Prevalence of EGFR (Epidermal Growth Factor Receptor) muTations in RUSsian Patients With Advanced NSCLC (Non-Small Cell Lung Cancer).CompletedNCT02321046
- A Phase 1 Study of MEDI0562 in Adult Subjects With Selected Advanced Solid TumorsCompletedNCT02318394Phase 1
- A PD/Safety Study of RDEA3170 in Combination With Febuxostat for Treating Gout or Asymptomatic Hyperuricemia PatientsCompletedNCT02317861Phase 1/2
- China Survey of Stress Ulcer Bleeding in Critically Ill Neurosurgical PatientsCompletedNCT02316990
- Long-term Follow-up of antithrombotIc Management Patterns in Acute Coronary Syndrome Patients in Asia-China ExtensionCompletedNCT02305680
- LUMINIST: LUng Cancer Molecular Insights Non Interventional StudyCompletedNCT02300831
- A Real-World Assessment of a COPD Disease Management Support Service (Me & My COPD)CompletedNCT02300090
- Acalabrutinib in Combination With Anti-CD20 and Venetoclax in Relapsed/Refractory or Untreated CLL/SLL/PLLCompletedNCT02296918Phase 1
- Natural History Study to Characterise the Course of Disease Progression in Participants With Mucopolysaccharidosis Type IIIBTerminatedNCT02293408
- A Retrospective Chart Review of Deceased Patients With Mucopolysaccharidosis Type IIIBCompletedNCT02293382
- RuSsian RegisTry of Acute CoronaRy SyndromE TreAtMent and Approach in Dual Antiplatelet TherapyCompletedNCT02288260
- Assess Safety, Tolerability, Pharmacokinetics and Clinical Activity of AMP-110 in Subjects With Rheumatoid ArthritisCompletedNCT02277574Phase 1
- An Observational Study of Respiratory Syncytial Virus (RSV) Hospitalizations in Preterm InfantsCompletedNCT02273882
- Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical RegistryCompletedNCT02271022
- Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer AgentsActive, not recruitingNCT02264678Phase 1
- A Phase I Study to Evaluate the Safety, Tolerability and Efficacy of MEDI4736 (Durvalumab) With Tremelimumab in Head and Neck CancerCompletedNCT02262741Phase 1
- OSCA - Olaparib Standard of CAre StudyCompletedNCT02262273
- A Phase 1 Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Solid TumorsCompletedNCT02261220Phase 1
- Phase I, Dose Study to Look at the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid TumoursCompletedNCT02260661Phase 1
- Forxiga (Dapagliflozin) Regulatory Postmarketing SurveillanceCompletedNCT02252224
- Non-interventional Study of Spirometry Use to Diagnose COPD (Chronic Obstructive Pulmonary Disease) and to Prescribe Treatment to COPD Patients in the Outpatient InstitutionsCompletedNCT02248909
- AZD9496 First Time in Patients Ascending Dose StudyCompletedNCT02248090Phase 1
- Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients With AL AmyloidosisCompletedNCT02245867Phase 1
- Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque PsoriasisCompletedNCT02239666
- CEntralized Pan-Russian Survey of tHE Undertreatment of hypercholeSterolemia II (CEPHEUS II)CompletedNCT02230241
- Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors, AZD3759 or AZD9291, in Patients Who Have Advanced Non-Small Cell Lung CancerCompletedNCT02228369Phase 1
- DISCOVERing Treatment Reality of Type 2 Diabetes in Real World Setting in JapanCompletedNCT02226822
- A Phase 1 Study to Evaluate MEDI6383 Alone and in Combination With MEDI4736 in Adult Subjects With Select Advanced Solid TumorsCompletedNCT02221960Phase 1
- A Double-blind, Placebo-controlled, Single-dose Study to Evaluate the PK, IM, and Safety in Japanese SubjectsCompletedNCT02213315Phase 1
- An Observational, Cross Sectional Study to Assess the Prevalence of Chronic Kidney Disease (CKD) in Type 2 Diabetes PatientsCompletedNCT02208921
- Forxiga Tablets Specific Clinical Experience Investigation for Long-term UseCompletedNCT02200666
- Forxiga Tablets Specific Clinical Experience Investigation for ElderlyCompletedNCT02200627
- Randomized, Crossover Safety and Pharmacokinetics Study of PT010CompletedNCT02197975Phase 1
- REalWorld Insights on the INitiation and Treatment Duration of ticagrEloR & Other Oral Antiplatelets (OAP) in Patients With Acute Coronary Syndrome (ACS) in Be/Lux.CompletedNCT02190123
- Pharmacokinetics and Safety Study of PT010 in Healthy SubjectsCompletedNCT02189304Phase 1
- Evaluation of Clinical Effectiveness of Roflumilast in Routine Practice, in Chronic Obstructive Pulmonary Disease (COPD) Patients in GreeceCompletedNCT02187926
- Study to Assess the Blood Levels and Safety of AZD9291 in Patients With Advanced Solid Tumours and Normal Liver Function or Mild or Moderate Liver ImpairmentCompletedNCT02161770Phase 1
- Acalabrutinib in Combination With ACP-319, for Treatment of Chronic Lymphocytic LeukemiaActive, not recruitingNCT02157324Phase 1
- Non-Interventional Study PREVENTCompletedNCT02155998
- Multicentric, Transversal, Descriptive, Epidemiological Study on the Management of Asthma in Asthmatic Middle East Adult PopulationCompletedNCT02153411
- Phase I Open Label Dose Escalation Study to Investigate the Safety & Pharmacokinetics of AZD5312 in Patients With Androgen Receptor TumorsCompletedNCT02144051Phase 1
- The Severity of Newly Diagnosed Asthma Patients and the Result of Initial 12 Weeks Treatment in ChinaCompletedNCT02143739
- AZD9291 in Combination With Ascending Doses of Novel TherapeuticsActive, not recruitingNCT02143466Phase 1
- Ph1 to Assess Safety, Tolerability of Tremelimumab/ Tremelimumab+MEDI4736 in Japanese Solid Malignancies/ MesotheliomaCompletedNCT02141347Phase 1
- Epidemiology of Chronic Bronchitis in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02128529
- Lesinurad Tablet BioequivalenceCompletedNCT02127775Phase 1
- A Phase I, Open-Label, Single-Center Study to Assess the Absorption, Metabolism, and Excretion of [14C]-AZD3293CompletedNCT02126514Phase 1
- OVArian Cancer Non-Interventional Study - OVATARCompletedNCT02122588
- Adenosine-induced Myocardial Blood Flow in Peripheral Artery Disease PatientsWithdrawnNCT02121288Phase 4
- Phase 1 Study to Evaluate MEDI4736 in Subjects With Myelodysplastic SyndromeCompletedNCT02117219Phase 1
- Efficacy and Safety Study of Two Dose Levels of AZD2115 in Subjects With Moderate to Severe COPDCompletedNCT02109406Phase 2
- A Cross Sectional Disease/Condition Focused Observational Study on Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02100332
- Observational Prospective Study OPTIMA II - Follow-upCompletedNCT02099565
- To Assess the Effect of Itraconazole and Fluconazole on the Pharmacokinetics of Selumetinib in Healthy Male VolunteersCompletedNCT02093728Phase 1
- Post-Marketing Surveillance Study: 12 To 24 Weeks Study On The Treatment Emergent Adverse Events In Patients With Type 2 Diabetes Taking Exenatide In KoreaCompletedNCT02090673
- Evaluation of Blood Brain Barrier Integrity and Structural Abnormalities in MPS IIIB Patients Using Multimodal Magnetic Resonance ImagingCompletedNCT02090179
- MEDI4736 (Anti PD-L1) Combined With Gefitinib in Subjects With Non-Small Cell Lung Cancer(NSCLC).CompletedNCT02088112Phase 1
- A First Time in Man Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD1979 in Healthy MalesTerminatedNCT02072993Phase 1
- Post Marketing Surveillance of Roflumilast in KoreaCompletedNCT02068456
- To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Renal Impaired Subjects and Healthy SubjectsCompletedNCT02063204Phase 1
- Bioequivalence/Food Effect - Saxa/Dapa Dual Fixed Dose Combination (FDC)CompletedNCT02060201Phase 1
- Clinical Practice of AECOPD Management in ChinaCompletedNCT02051166
- A Study to Evaluate the Clinical Epidemiology of Patients With Heart Failure (HF) in IndiaWithdrawnNCT02047526
- To Assess the Effect of Rifampicin on the Pharmacokinetics of Selumetinib in Healthy Male VolunteersCompletedNCT02046850Phase 1
- AZD3293 Thorough QT Study in Healthy Male VolunteersCompletedNCT02040987Phase 1
- Bioavailability of Lesinurad and Intravenous [14C]LesinuradCompletedNCT02039700Phase 1
- Relative Bioavailability Study to Assess Two Solid Formulations Compared to an Oral Solution of AZD3293 in Healthy Male and Non-Fertile Female SubjectsCompletedNCT02039180Phase 1
- Metformin and Furosemide Drug-Drug Interaction StudyCompletedNCT02028689Phase 1
- Phase 1 Safety and Tolerability of MEDI4736 in Combination With Dabrafenib and Trametinib or With Trametinib AloneCompletedNCT02027961Phase 1
- Explore the Performance of IntelliCap.CompletedNCT02025348Early Phase 1
- Patient Registry of Roflumilast In Real LifeCompletedNCT02015767
- A Phase 1 Multicenter Open-label Study to Evaluate the Safety Tolerability and PK of MEDI0680 (AMP-514) in Subjects With Advanced MalignanciesCompletedNCT02013804Phase 1
- A Phase I Study in Healthy Volunteers to Assess the Effect of Cytochrome3A4 (CYP3A4) Inhibitors (Diltiazem and Itraconazole) on the Pharmacokinetics (PK) of AZD3293 and the Effects of AZD3293 on the Pharmacokinetics of Midazolam, a Cytochrome 3A4 and Cytochrome 3A5 (CYP3A4/CYP3A5) SubstrateCompletedNCT02010970Phase 1
- REal World Information on Cardiovascular Drug Management Patterns in Acute Coronary Syndrome paTientsCompletedNCT02001545
- A Phase 1b Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Non-small Cell Lung CancerCompletedNCT02000947Phase 1
- A Case Control Study of the Effectiveness of Q/LAIV Versus Inactivated Influenza Vaccine and No Vaccine in Subjects 2-17 Years of AgeTerminatedNCT01997450
- Study to Investigate Relative Bioavailability of up to Five Different Formulations of AZD5069CompletedNCT01989520Phase 1
- Lesinurad Tablet Relative BioavailabilityCompletedNCT01986556Phase 1
- Postmarketing Safety Study of Q/LAIV in Subjects 2 Through 49 Years of AgeCompletedNCT01985997
- A Retrospective Swedish Cohort Study on Health Outcomes, Life Expectancy, Resource Use and Costs in Patients With a History of Myocardial Infarction and Additional Risk Factors for AtherothrombosisCompletedNCT01984307
- Antacid Interaction StudyCompletedNCT01982201Phase 1
- Phase I Study Evaluating the Safety and Pharmacokinetics of Budesonide, Glycopyrronium, and Formoterol Fumarate Inhalation Aerosol (BGF MDI) in Healthy VolunteersCompletedNCT01980615Phase 1
- Retrospective Observational Study DIANA StudyCompletedNCT01976793
- To Assess the Effect of Food on the Pharmacokinetics of Selumetinib (AZD6244; ARRY-142886) (Hyd-Sulfate) in Healthy Male VolunteersCompletedNCT01974349Phase 1
- BE Study Between a Capsule and a Sachet Formulation of D961H by Pharmacodynamics in Japanese Healthy Male SubjectsCompletedNCT01964131Phase 1
- Study to Investigate Safety, Tolerability and Effect of Multiple Dosing With AZD 4721 and/or With AZD 5069CompletedNCT01962935Phase 1
- Dose-escalation Study to Assess Selumetinib Safety, Tolerability and PKCompletedNCT01960374Phase 1
- A Retrospective, Non-interventional, Multicenter, Observational Chart Review Study to Explore the Clinical Benefits of Retreatment With TKI in the Real World.CompletedNCT01955681
- AZD6738 First Time in Patient Multiple Ascending Dose StudyCompletedNCT01955668Phase 1
- Prevention of Cardiovascular Events by Antiplatelet Agents After Acute Coronary SyndromeCompletedNCT01952392
- To Determine the Relative Bioavailability of Different Formulations of AZD9291 and the Effect of Food.CompletedNCT01951599Phase 1
- Evaluation of Symptoms Improvement in NSCLC Patients With First-Line Therapy of EGFR Tyrosine Kinase InhibitorCompletedNCT01947868
- forREAL: FORXIGA PRESCRIPTION EVENT MONITORING PROGRAM (PEMP)TerminatedNCT01944618
- Specific Clinical Experience Investigation for Long-term Use of Bydureon.CompletedNCT01940770
- A Phase I, Open-Label, Multicentre Study to Evaluate the Safety, Tolerability and Pharmacokinetics of MEDI4736 in Patients With Advanced Solid TumoursCompletedNCT01938612Phase 1
- Study to Investigate the Effect of a Single Dose of AZD7624 on Inflammation Caused by an Endotoxin ChallengeCompletedNCT01937338Phase 1